CYNTHIA SLEPPY: Open Payments
NPI 1336445469 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 60 payments from 6 companies in 2025. Trend: 2023 $990 · 2024 $1,510 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 34 | $670 |
| ViiV Healthcare Company | 20 | $507 |
| Exact Sciences Corporation | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: CABENUVA, APRETUDE, RUKOBIA, Biktarvy, DOVATO, Cologuard Collection Kit, XIFAXAN, PIFELTRO.
Industry payments across FL — which companies pay providers there.
